earnings digest brief dr reddys laboratories ltd net rises on lower costs foreign exchange gain indian pharmaceuticals company dr reddys laboratories ltd s fiscal first quarter profit rose even as revenue declined because of lower contributions from several business segments consolidated net profit for the quarter ended june rose to billion rupees &# million from billion rupees a year earlier the average of a dow jones poll of analysts had estimated net profit at billion rupees "we controlled selling general and administration expenses very well we will continue to improve profitability by driving down costs further " dr reddys chief executive g v prasad said selling general and administration expenses decreased to billion rupees the company recorded a foreign exchange gain of million rupees compared with a foreign exchange loss of million rupees a year earlier revenue fell to billion rupees from billion rupees revenue from the generic finished dosages segment was billion rupees in the quarter compared with billion rupees in the year earlier period 
